She is currently conducting a multisite follow-up study with researchers at New York University to investigate the treatments effects on withdrawal
When you stop, appetite typically returns but if weve addressed the underlying metabolic dysfunction during that time, rebound is much less dramatic
Zepbound is also available as a KwikPen, a prefilled, ready-to-use injectable device that contains four doses in a single pen for added convenience
Mechanism Avg % weight loss (placebo subtracted) Dosing Side effects Cost Semaglutide GLP-1 receptor agonist : (increases insulin secretion, suppresses appetite, enhances satiety, slows gastric emptying) STEP 1 14.9% (68 weeks) STEP 5 (120 weeks): -16.5% ~1517% average sustained loss 20% loss in ~17% of users 2.4mg weekly Nausea (44%) Diarrhea (30%) Vomiting (24%) Constipation (23%) Headache, fatigue Varies widely but generally the cheaper of the two
You should contact your GP or diabetes care team if: Urinary frequency significantly increases or becomes bothersome You experience pain, burning, or discomfort when urinating Urine appears cloudy, bloody, or has a strong odour You develop excessive thirst alongside increased urination You experience symptoms of dehydration (dizziness, dry mouth, dark urine) For urgent but non-emergency concerns, contact NHS 111 for advice
In clinical trials, patients using liraglutide typically lost around 58% of their body weight , compared to placebo groups (FDA approval summary for Saxenda)